Impaired Autologous Mixed Lymphocyte Reactivity in Hodgkin's Disease

Overview

Journal Klin Wochenschr

Specialty General Medicine

Date 1982 Jan 4

PMID 6210797

Authors

M Begemann

G Claas

H Falke

Affiliations

Soon will be listed here.

Abstract

In patients with Hodgkin's disease, the impaired immune reactivity, especially of the thymus dependent system, is well established. This decreased immune response of the lymphocytes from the peripheral blood contrast to an increased lymphocytopoiesis in the the lymphatic organs with a hyperplasia of these tissues. We studied the reactivity of peripheral T lymphocytes from 20 patients with Hodgkin's disease and 26 healthy control persons against autologous and allogeneic non T cells respectively in the mixed lymphocyte culture (MLC). Our experiments show an extremely depressed autologous mixed lymphocyte reactivity (MLR) of T lymphocytes from patients with Hodgkin's disease compared to those from normal donors. In the allogeneic MLC, the proliferation of the patients' T cells was stronger than in the autologous MLC, but significant lower than the proliferation of normal T lymphocytes when stimulated by normal non T cells. Patients' non T cells stimulated T lymphocytes from healthy donors as well as non T lymphocytes from normals did. Finally, the autologous MLR of normal lymphocytes was significantly suppressed by 18 of 23 sera from Hodgkin's patients when these sera were substituted for normal AB serum in the cultures. These results demonstrate an impaired function of T lymphocytes from patients with Hodgkin's disease in the autologous MLC and the presence of one or more factors in their serum which inhibit the proliferation of normal lymphocytes in the autologous MLC. The role of suppressor cells and their factors will be discussed.

References

Sakane T, Green I . Specificity and suppressor function of human T cells responsive to autologous non-T cells. J Immunol. 1979; 123(2):584-9. View

Opelz G, Kiuchi M, Takasugi M, Terasaki P . Autologous stimulation of human lymphocyte subpopulation. J Exp Med. 1975; 142(5):1327-33. PMC: 2189968. DOI: 10.1084/jem.142.5.1327. View

Webb D, Nowowiejski I . Mitogen-induced changes in lymphocyte prostaglandin levels: a signal for the induction of suppressor cell activity. Cell Immunol. 1978; 41(1):72-85. DOI: 10.1016/s0008-8749(78)80029-x. View

Goodwin J, Bankhurst A, Messner R . Suppression of human T-cell mitogenesis by prostaglandin. Existence of a prostaglandin-producing suppressor cell. J Exp Med. 1977; 146(6):1719-34. PMC: 2181914. DOI: 10.1084/jem.146.6.1719. View

Smith J, Knowlton R . Activation of suppressor T cells in human autologous mixed lymphocyte culture. J Immunol. 1979; 123(1):419-22. View

Webb Jr D, Jamieson T . Control of mitogen-induced transformation: characterization of a splenic suppressor cell and its mode of action. Cell Immunol. 1976; 24(1):45-57. DOI: 10.1016/0008-8749(76)90130-1. View

Offner H, Clausen J . Letter: Inhibition of lymphocyte response to stimulants induced by unsaturated fatty acids and prostaglandins. Lancet. 1974; 2(7877):400-1. DOI: 10.1016/s0140-6736(74)91774-7. View

ORDER S, Hellman S . Pathogenesis of Hodgkin's disease. Lancet. 1972; 1(7750):571-3. DOI: 10.1016/s0140-6736(72)90360-1. View

Vande Stouwe R, KUNKEL H, Halper J, Weksler M . Autologous mixed lymphocyte culture reactions and generation of cytotoxic T cells. J Exp Med. 1977; 146(6):1809-14. PMC: 2181897. DOI: 10.1084/jem.146.6.1809. View

10.

Miller R, Kaplan H . Generation of cytotoxic lymphocytes in the autologous mixed lymphocyte culture. J Immunol. 1978; 121(6):2165-7. View

11.

Romagnani S, Maggi E, Biagiotti R, Giudizi M, Amadori A, Ricci M . Altered proportion of T mu-and T gamma-cell subpopulations in patients with Hodgkin's disease. Scand J Immunol. 1978; 7(6):511-4. DOI: 10.1111/j.1365-3083.1978.tb00485.x. View

12.

Devita Jr V . Lymphocyte reactivity in Hodgkin's disease: a lymphocyte civil war. N Engl J Med. 1973; 289(15):801-2. DOI: 10.1056/NEJM197310112891510. View

13.

TREPEL F, Schick P . [Hodgkin's disease--an atypical immune reaction]. Med Klin. 1977; 72(23):1003-18. View

14.

Long J . The immunopathology of Hodgkin's disease. Clin Haematol. 1979; 8(3):531-66. DOI: 10.1016/s0308-2261(79)80003-x. View

15.

Bach F, Voynow N . One-way stimulation in mixed leukocyte cultures. Science. 1966; 153(3735):545-7. DOI: 10.1126/science.153.3735.545. View

16.

Goodwin J, Messner R, Bankhurst A, Peake G, Saiki J, Williams Jr R . Prostaglandin-producing suppressor cells in Hodgkin's disease. N Engl J Med. 1977; 297(18):963-8. DOI: 10.1056/NEJM197711032971802. View

17.

Boyum A . Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl. 1968; 97:77-89. View

18.

Bieber M, Fuks Z, Kaplan H . E-rosette inhibiting substance in Hodgkin's disease spleen extracts. Clin Exp Immunol. 1977; 29(3):369-75. PMC: 1541080. View

19.

Weksler M, Kozak R . Lymphocyte transformation induced by autologous cells. V. Generation of immunologic memory and specificity during the autologous mixed lymphocyte reaction. J Exp Med. 1977; 146(6):1833-8. PMC: 2181889. DOI: 10.1084/jem.146.6.1833. View

20.

Hillinger S, Herzig G . Impaired cell-mediated immunity in Hodgkin's disease mediated by suppressor lymphocytes and monocytes. J Clin Invest. 1978; 61(6):1620-7. PMC: 372688. DOI: 10.1172/JCI109082. View